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ARTICLE
Gross-total resection of temporal low grade 
gliomas is a critically important factor in 
achieving seizure-freedom
A ressecção total de gliomas temporais de baixo grau é um importante fator no controle 
das crises convulsivas
Lucas Crociati Meguins1, Rodrigo Antônio Rocha da Cruz Adry1, Sebastião Carlos da Silva Júnior1, Carlos 
Umberto Pereira2, Jean Gonçalves de Oliveira3,4, Dionei Freitas de Morais1, Gerardo Maria de Araújo Filho5, 
Lúcia Helena Neves Marques6
Epileptic seizures are a common manifestation of brain 
tumors, frequently the presenting symptom and the main 
factor influencing quality of life1,2,3. The incidence of tumors 
in patients with chronic epilepsy has been reported to range 
from 10% to 50%4,5. Among these, low-grade gliomas (LGG) 
are the most common, with a variety of other histological 
entities reported6. Almost two-thirds of patients with supra-
tentorial gliomas had seizures7. Although the precise nature 
of epileptogenesis is still unclear, glutamate release by glioma 
cells has recently been shown as a possible cause of seizures8 
and slowly progressive tumors near the cortex are described 
to be associated with a high incidence of seizures9.
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ABSTRACT
Objective: To present a surgical series of patients with low grade temporal gliomas causing intractable epilepsy, focusing on long-term 
seizure outcome. Method: A retrospective study was conducted with patients with temporal low-grade gliomas (LGG). Results: Sixty 
five patients with were operated in our institution. Males were more affected than females and the mean age at surgery was 32.3 ± 8.4 
(9-68 years). The mean age at seizure onset was 25.7 ± 9.2 (11-66 years). Seizure outcome was classified according with Engel classification. 
After one year of follow up, forty two patients (64.6%) were Engel I; seventeen (26.2%) Engel II; four (6.2%) Engel III and two (3.1%) Engel IV. 
Statistically significant difference in seizure outcome was obtained when comparing the extension of resection. Engel I was observed in 39 
patients (69.6%) with total resection and in only 3 (33.3%) patients with partial resection. Conclusion: Gross-total resection of temporal 
LGGs is a critically important factor in achieving seizure-freedom. 
Keywords: temporal low-grade gliomas, intractable epilepsy, long-term seizure outcome.
RESUMO
Objetivo: Apresentar uma série cirúrgica de pacientes com gliomas temporais de baixo grau, causando epilepsia de difícil controle. Método: 
Estudo retrospectivo de pacientes com diagnóstico de glioma temporal de baixo grau temporais. Resultados: 65 pacientes com foram 
operados em nossa instituição. A média de idade de início das crises foi de 25,7 ± 9,2 (11-66 anos). Após um ano de acompanhamento, 
quarenta e dois pacientes (64,6%) estavam Engel I; dezessete (26,2%) Engel II; quatro (6,2%) Engel III e dois (3,1%) Engel IV. Houve diferença 
estatisticamente significativa no resultado do controle das crises quando se compara a extensão da ressecção. Engel I foi observada em 39 
pacientes (69,6%) com a ressecção total e em apenas 3 (33,3%) pacientes com ressecção parcial. Conclusão: A ressecção total de glioma 
temporal de baixo grau temporais é um fator extremamente importante no controle das crises.
Palavras-chave: glioma temporal de baixo grau, epilepsia de difícil controle, controle das crises.
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Resection is often recommended to patients with epilep-
tic seizures harboring a brain tumor. Clinical studies from 
several epilepsy centers specifically report favorable seizure 
outcome in patients who had surgery on temporal LGG10,11,12,13. 
However, unfortunately there is still no standard surgical ap-
proach, with some authors advocating lesionectomy alone 
and others arguing for more extensive resection10,11,12,13,14. The 
aim of the current investigation is to present a surgical series 
of patients with temporal LGG causing intractable epilepsy, 
focusing on long-term seizure outcome.
METHOD
Study delineation
A retrospective observational investigation was con-
ducted with data collection from all patients treated in the 
epilepsy clinic of a Brazilian tertiary referral center. Patients 
selected were diagnosed with temporal LGG from January 
1995 to March 2013. Clinical data were obtained retrospec-
tively. For all patients with the diagnosis of temporal LGG on 
magnetic resonance images (MRI), the following data were 
collected: gender, age at surgery, handedness, type and num-
ber of antiepileptic drugs (AEDs) used and results of formal 
neuropsychological evaluations. The present study was ap-
proved by the Ethical Committee of our institution.
Patients with temporal LGG were included in the pres-
ent investigation when fulfilling all the following crite-
ria: (1) temporal lobe involvement only; (2) presence of 
preoperative MRI, neurophysiologic investigation with 
video-electroencephalogram (EEG) and neuropsychologi-
cal assessment; (3) at least 1 year of clinical and radiological 
follow-up and (4) patients operated by an epilepsy surgeon 
with the same surgical strategy.
Pre-surgical evaluation
Patients were submitted to video-EEG monitoring using 
the Neuro Workbench software and a Nihon Kohden hard-
ware. Every patient was analyzed by an experienced epilep-
tologist as an integral part of inpatient assessment.
All patients were submitted to a neuropsychological as-
sessment pre- and post-surgically (at 12 months). Verbal 
memory was assessed by a list of learning design, and fig-
ural memory by a design learning test using independent 
items. Memory deficits were defined as performance one 
standard deviation below of the normal performance of 
age-matched controls.
Brain MRI was obtained accordingly with a specific ep-
ilepsy protocol using a 1.5 Tesla Scanner. All MRIs were 
analyzed by an experienced neuroradiologist that confirmed 
the radiological diagnosis of temporal lobe LGG. Location of 
the tumor was divided into (1) mesial – mesial to the collat-
eral sulcus (mainly the parahippocampal gyrus, hippocam-
pus, amigdalum and uncus); (2) lateral – all structures lateral 
to the collateral sulcus and (3) whole temporal lobe – if both 
mesial and lateral parts were involved. All patients had MRI 
within 72 hours of surgery and in every year of follow-up. MRI 
was also obtained in order to see any recurrence.
The surgical extension of resection on temporal lobe LGG 
mainly depended on two factors: (1) proximity or involve-
ment of mesial structures and (2) hemispheric dominance. 
The standard surgical approach on non-dominant hemi-
spheres was anterior temporal resection with amygdalohip-
pocampectomy whether the mesial structures were involved 
or not. However, on the dominant hemisphere the surgical 
approach mainly depended on neuropsychological testing: 
extended lesionectomy was performed if mesial structures 
were not involved and only partial resection when mesial 
structures were involved due to the high risk of severe mem-
ory problems.
Biopsy specimens were collected from all patients with 
chronic drug-resistant and radiological evidence of tempo-
ral LGG, who underwent surgical treatment. Standardized 
neuropathological analysis was performed in all patients 
under study. Surgical specimens submitted for neuropatho-
logical evaluation were microscopically analyzed by using 
hematoxylin-eosin staining. The pathologist reported their 
findings without clinical or imaging data.
Outcome assessments and follow-up
Follow-up investigations were carried out in operated 
patients. At the 12 months follow-up, all patients received 
a neurological examination including observation of behav-
ior disorders, exploration of seizure outcome and a cerebral 
1.5 Tesla MRI. Seizure outcome was classified according with 
Engel classification15.
Statistical analysis
Averages are expressed as the mean ± standard deviation 
(SD) for parametric data and as median values for nonpara-
metric data. Statistical analysis was performed utilizing the 
Fisher’s exact test. Long-term seizure outcome and surgi-
cal survival rate was assessed using Kaplan-Meier curves. A 
p-value < 0.05 was considered statistically significant.
RESULTS
A total of 69 patients with medically intractable epilep-
sy and pathologically confirmed tumors were identified and 
operated. Four patients were excluded from this sample be-
cause they did not reach a minimum one year of follow up.
Table 1 shows the clinical findings of 65 patients operated 
with temporal LGG.
Table 2 shows the summary of surgical findings of 65 
patients operated with temporal LGG. We preferably per-
formed total resection in order to have favorable seizure out-
come and to decrease the chance of recurrence and tumor 
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upgrade. On the right side, anterior temporal lobe resection 
with amygdalohippocampectomy was generally preferred. 
On the left hemisphere (generally dominant), we common-
ly respected the mesial structures due to the risk of severe 
memory. We had 9 patients (13.8%) in whom partial resec-
tion was performed due to the dominance of memory, al-
though tumor involvement was documented. They are still 
under follow-up without any clinical or radiological deterio-
ration. Two cases (3.1%) needed reoperation because of tu-
mor recurrence, one patient with diffuse astrocytoma and 
one patient with oligodendroglioma.
Table 3 shows the summary of seizure outcome of 65 
patients operated with temporal LGG. The seizure-free sur-
vival rate of our series over time was illustrated through a 
Kaplan-Meier curve observed in Figure.
Table 4 summaries the complications related to surgery 
of 65 patients with temporal LGG. However, it is important 
to note that as not all patients performed ophthalmologi-
cal examination after surgery, it is difficult to provide exact 
rate of visual field defects. There was no surgical mortality 
in this study.
Histopathological diagnosis is described in Table 5.
Memory deficits were observed in 8 (88.9%) of 9 patients 
(13.8%) in whom subtotal resection of mesial structures was 
performed due to the dominance of memory, although tumor 
involvement was documented. Partial recovery of memory 
was noted in seven patients during follow up, however not 
reaching the normal limits for age. Of those patients with 
tumor on the non-dominant side, memory was shown to be 
preserved during follow up and all returned to work and nor-
mal daily life.
DISCUSSION
Most patients with LGG experience epileptic seizures 
as a presenting symptom16,17,18. Clinically, tumor-related sei-
zures manifest as simple or complex partial seizures with 
or without secondary generalization19 and, in more than 
50% of cases, are pharmacoresistant20. When uncontrolled, 
tumor-related epilepsy affects patients’ quality of life, causes 
Table 1. Clinical findings of 65 patients operated with temporal LGG.
Number of cases/%
Gender
Female 28/43.1
Male 37/56.9
Mean age at surgery (years) 32.3 ± 8.4 (9-68 years)
Mean age at seizure onset (years) 25.7 ± 9.2 (11-66 years)
Seizure frequency/months 18.2 ± 38.7 (1-120)
Time from seizure onset to surgery (years) 9.4 ± 6.9 (1-27 years)
Seizure type
Partial complex 46/70.8
Tonic-clonic generalized 17/26.2
Multiple 2/3.0
EEG Findings
Lateralized 51/78.5
Concordanta 51/100
Bilateral 8/12.3
Normal 6/9.2
Hemispheric dominance
Right 4/6.2
Left 61/93.8
Mean follow-up (years) 6.9 ± 4.3 (1-12 years)
a Concordance according to lesion side; LGG: low-grade glioma.
Table 2. Surgical findings of 65 patients operated with 
temporal LGG.
Number of cases/%
Side of surgery
Right 39/60.0
Left 26/40.0
Total resection 56/86.2
Partial resection 9/13.8
Location
Right side
Mesial removed 35/89.7
Mesial Spared 4/10.3
Left side
Mesial removed 16/61.5
Mesial Spared 10/38.5
Sub-location
Mesial only 28/43.1
Mesial removed 26/92.9
Mesial Spared 2/7.1
Lateral only 13/20
Mesial removed 2/15.4
Mesial Spared 11/84.6
Whole temporal 24/36.9
Mesial removed 17/70.8
Mesial Spared 7/29.2
Recurrence or residue 11/16.9
Reoperation 2/3.1
LGG: low-grade glioma.
Table 3. Seizure outcome of 65 patients operated with 
temporal LGG.
Engel Classification (n/%)
I II III IV 
Side of surgery
Right (39/60.0) 26/66.7 10/25.6 2/5.1 1/2.6
Left (26/40.0) 16/61.5 7/26.9 2/7.7 1/3.8
Extension of resection*
Total (56/86.2) 39/69.6 14/25.0 2/3.6 1/1.8
Partial (9/13.8) 3/33.3 3/33.3 2/22.2 1/11.1
Age group
> 40 years (24/36.9) 15/62.5 7/29.2 1/4.2 1/4.2
< 40 years (41/63.1) 27/65.9 10/24.4 3/7.3 1/2.4
Mesial structures
Removed (51/78.5) 33/64.7 14/27.4 4/7.8 0/00.0
Spared (14/21.5) 9/64.3 3/21.4 0/00.0 2/14.3
Total (n = 65) 42/64.6 17/26.2 4/6.2 2/3.1
LGG: low-grade glioma; *: Fisher exact test, p < 0.05 (Engle I).
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cognitive deterioration, and may result in significant morbid-
ity21,22. In the present study, we have shown that males were 
more affected than females without a clear explanation and 
clinical symptoms usually appear in young age. Partial com-
plex seizures were the most common type in our study and in 
similar investigations in other epilepsy centers10,11,12,13,19.
There are still several controversies regarding surgical 
treatment of patients with temporal LGG and no standard 
guide exists showing the best surgical approach to this pa-
tients. There have been mainly four types of surgery includ-
ing standard anterior temporal resection only, standard an-
terior temporal with amygdalohippocampectomy, extended 
lesionectomy with amygdalo-hippocampectomy and extended 
lesionectomy19,23,24,25,26. We generally performed the follow-
ing protocol: in non-dominant temporal lobe, tumor removal 
was done by standard anterior temporal with amygdalohip-
pocampectomy; but in case of dominant side, we respected 
the mesial structures and performed extended lesionectomy. 
When the mesial structures where involved by the tumor in 
the dominant side, we generally performed only partial resec-
tion (1-2cm) of the mesial components and followed the pa-
tient radiologically. This protocol is in agreement with groups 
that believe that tumors should be removed totally when fea-
sible without adding any neurological deficits19. In the present 
study, fifty six patients (86.2%) had total resection and 9 pa-
tients (13.8%) partial resection, one in the right lobe and eight 
in the left. Memory deficits were observed in eight (88.9%) out 
of 9 patients. As long as the decision of whether or not partially 
remove the mesial structures on the dominant side affected by 
tumor is an extremely controversial theme on the international 
literature, we based our decision four mean topics: (1) accord-
ing to the patient’s wishes, (2) amount of involvement of the 
mesial structures, (3) clinical conditions of the patient and (4) 
the functional reserve of memory established by pre-operative 
neuropsychological evaluation. Although a systematic scheme 
was propose, still more than 85% of patients evolved memory 
deficits. We believe a great amount of investigational studies 
addressing this issue are necessary to improve tumor control 
and quality of life of patients involvement of mesial structures 
on the dominant side.
Regardless of the type of resection, most investigations have 
proved surgery as an effective mean to control seizure in pa-
tients with temporal LGG (10-14, 19, 20). Early operative inter-
vention12, gross-total resection14, shorter history of seizure27,28 
and preoperative seizure frequency28 are other factors associ-
ated with seizure freedom in the surgical resection of temporal 
LGG. We had satisfactory rate of favorable seizure outcome, 
reaching 69.6% of seizure freedom (Engel I) and 88.8% of good 
clinical control (Engel I and II), which was in agreement with 
other clinical studies10,11,12,13,14,19,20. The extension of resection 
proved to be a statistically significant factor associated direct-
ly with better seizure outcome. In the present study, postop-
erative Engel I was observed in 39 patients (69.6%) with total 
resection and in only 3 (33.3%) patients with partial resection 
(Fisher exact test, p-value = 0.0435). The authors believe that 
removing as much tumor as possible, the surgeon will not only 
eliminate the epileptogenic action of tumor compression over 
the parenchyma, but also reduce the effect of epileptogenic 
substances released by glioma cells, such as glutamate, that 
have been proved as a possible cause of seizures8.
Few discrepancies exist in the histopathological diagno-
sis of temporal LGG and most studies agree that gangliogli-
omas are the most common tumor type followed by DNET, 
astrocytomas and oligodendrogliomas4,19,28,29. Our results re-
inforces that gangliogliomas are the leading neoplastic cause 
of refractory epilepsy of the temporal lobe. Glagliogliomas 
comprised 36.9%, followed by DNET with 21.5%, diffuse 
Figure. Kaplan-Meier curve showing the seizure-free survival 
rate over time of 65 patients with temporal LGG submitted to 
surgical treatment.
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Table 4. Complications related to surgery of 65 patients with 
temporal LGG.
Number of cases/%
Infection 8/57.1
Contralateral hemiparesis 2/14.3
Visual field deficits 4/28.6
Total 14/21.5
LGG: low-grade glioma.
Table 5. Histopathological diagnosis of 65 patients operated 
with temporal LGG.
Tumor (WHO grade) Number of cases/%
Ganglioglioma (I) 24/36.9
DNETa (I) 14/21.5
Diffuse astrocytoma (II) 11/16.9
Oligodendroglioma (II) 9/13.8
Pleomorphic xanthoastrocytoma (II) 4/6.2
Othersb 3/4.6
a Dysembroplastic neuroepithelial tumor; b: mixed 
oligodendroglioma/astrocytoma and astroblastoma; 
LGG: low-grade glioma.
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astrocytoma with 16.9%, oligodendroglioma with 13.8% and 
pleomorphic xanthoastrocytoma with 6.2%.
There are several methodological aspects in the present 
findings, which should be interpreted in the context of a num-
ber of limitations. Firstly, this study is a non-randomized retro-
spective investigation performed in a highly selected population 
of a tertiary epilepsy center. Secondly, these findings cannot be 
generalized for all types of tumors since only patients with LGG 
where included on the present investigation. On the other hand, 
the present study described the surgical outcomes of a relatively 
large number of patients that underwent surgery due to this pa-
thology for a relatively extended follow-up duration.
In conclusion, the present study highlights that tempo-
ral LGGs are a significant etiology of intractable epilepsy and 
gross-total resection of the lesion is a critically important 
factor in achieving seizure-freedom.
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